Consequently, risk stratification, including the use of tumor stage (TNM staging), tumor grade (Gleason score), and prostate specific antigen (PSA) levels, has played an important role in guiding management of men with PCa (3, 4). This evidence concerns the gene KLK3 and posterior cortical atrophy.